878672-60-7

Basic information

• Product Name: tert-butyl 2-(5-bromo-2-nitrophenyl)ethanoate
• Synonyms: tert-butyl 2-(5-bromo-2-nitrophenyl)ethanoate
• CAS NO: 878672-60-7
• Molecular Weight: 316.151
• Mol File: 878672-60-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: tert-butyl 2-(5-bromo-2-nitrophenyl)ethanoate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 2-(5-bromo-2-nitrophenyl)ethanoate(878672-60-7)
• EPA Substance Registry System: tert-butyl 2-(5-bromo-2-nitrophenyl)ethanoate(878672-60-7)

Safety Data

• Hazardous Substances Data: 878672-60-7(Hazardous Substances Data)

Upstream product

• 107-59-5 tert-Butyl chloroacetate 
• 586-78-7 para-nitrophenyl bromide 

Downstream Products

• 1374399-66-2 tert-butyl 2-(5-bromo-2-nitrophenyl)propanoate 
• 335201-57-5 2-(5-bromo-2-nitrophenyl)propan-1-ol 
• 1374399-75-3 ANPB-DDAO 
• 1374399-70-8 EANBP-GABA-MBA 
• 1374399-71-9 CANBP-GABA-MBA 
• 1374399-60-6 2-(2-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-ol 
• 702641-01-8 2-(5-bromo-2-iodophenyl)acetic acid 
• 52548-54-6 2-(5-bromo-2-(phenylthio)phenyl)acetic acid 
• 1033265-31-4 tert-butyl 2-(5-bromo-2-nitrophenyl)propenoate 
• 878673-09-7 tert-butyl 2-(2-amino-3-methylphenyl)acetate 
• 878672-61-8 2-(5-bromo-2-nitrophenyl)ethanol 

Relevant articles and documents

Light-induced protein dimerization by one- And two-photon activation of gibberellic acid derivatives in living cells

We developed a highly efficient system for light-induced protein dimerization in live cells using photo-caged derivatives of the phytohormone gibberellic acid (GA3). We demonstrate the application of the photo-activatable chemical inducer of di

COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES

The invention provides novel tricyclic compounds of Formula (I) that inhibit B-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.

DEVELOPMENT OF FLUOROGENIC SUBSTRATES FOR MONOAMINE OXIDASES (MAO-A AND MAO-B)

The present invention relates to compounds useful for detecting the activity of monoamine oxidases, compounds useful for competitively inhibiting monoamine oxidases, for determining inhibitors of monoamine oxidases and compounds useful for treating monoamine oxidase-related nervous system pathologies, as well as pharmaceutical compositions and methods of manufacture thereof.